EpiEndo Pharmaceuticals is a pharmaceutical company focused on novel solutions for chronic airway diseases.
EpiEndo Pharmaceuticals has raised €25M across 3 funding rounds from 4 investors, most recently a Series A round in Aug 2021. Based in Reykjavík, Iceland; founded 2014; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2021-08-18 | Series A | €20M | Iðunn Venture Fund,ABC Ventures,European Innovation Council (EIC),Flerie Invest | View deal → |
| 2019-10-01 | Grant | €4.5M | — | View deal → |
| 2019-01-01 | Other | €800k | — | View deal → |
